Skip to main content
Gabriel Brooks, MD, Cardiology, Boston, MA

Gabriel C Brooks MD MAS FACC

Cardiology•Boston, MA

Non-Invasive Cardiology

Chief Medical Officer, Solid Biosciences

Join to View Full Profile

  • 500 Rutherford AveBoston, MA 02129

  • Phone+1 510-603-9193

Dr. Brooks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Brooks' Full ProfileAlready have an account?

Summary

  • Dr. Gabriel Brooks is the Chief Medical Officer and leads the clinical function for all of Solid’s neuromuscular and cardiac programs.

    Dr. Brooks has served as the Chief Medical Officer for Solid Biosciences since October 2023, having previously led the Rare Disease Research Unit at Pfizer as Rare Cardiovascular Therapeutic Area Head from September 2020.

    Between September 2020 and September 2023, Dr. Brooks directed the translational development of a range of precision AAV gene therapies for dilated, arrhythmogenic, and hypertrophic cardiomyopathies, at Pfizer. Dr. Brooks also served as the vice president of research and development at 4D Molecular Therapeutics from November 2018 to September 2020, where he oversaw translational development of AAV gene therapies for Anderson Fabry, as well as the first-in-human dosing of AAV gene therapies for two ophthalmologic indications (choroideremia and X-linked retinitis pigmentosa). From April 2017 to November 2018, Dr. Brooks led a successful Phase III registrational study of flurpiridaz at GE Life Sciences, and led several cardiovascular clinical trials in rare and large market indications during his time at Gilead Life Sciences between August 2015 and April 2017.

    Dr. Brooks received a Bachelor of Science in Biology from Carnegie Mellon University, a Doctor of Medicine from Cornell University, and a Master of Applied Sciences of Biostatistics and Epidemiology from the University of California, San Francisco. He completed his training in Internal Medicine at Johns Hopkins Hospital, Baltimore, and fellowships in general Cardiology and Advanced Imaging at the University of California, San Francisco.

Education & Training

  • University of California
    University of CaliforniaMAS, Clinical Research (Epi/Bio-Stats), 2013 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Cardiovascular Disease, 2011 - 2014
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2008
  • Carnegie Mellon University
    Carnegie Mellon UniversityB.S., Biology, 1995 - 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2027
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Scholar Mayo Clinic Cardiovascular Board Review, 2013

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension  
    Kallianos K, Higgins C, Odrovas K, J Cardiovasc Magn Reson, 1/1/2015
  • An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy  
    Heise C, Hermiston T, Johnson L, Sampson-Johannes A, Williams A, Hawkins L, Kirn D, Nature Medicine, 1/1/2000

Abstracts/Posters

  • The Association Between Clinical and Echocardiographic Imaging Findings and T2 in End Stage Liver Disease
    Brown K, Mehta N, Rubin N, Foster E, Qasim A., American Heart Association, 1/1/2015
  • Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension
    Kallianos K, Higgins C, Ordovas K., Society for Cardiac Magnetic Resonance, Nice, 1/1/2015
  • Diagnostic Accuracy of a Smartphone based Six-Minute Walk Test
    Vittinghoff E, Sivaraman I, Marcus G, Olgin J, American Heart Association, 1/1/2014
  • Join now to see all

Lectures

  • Classifying lung cancer stage from health care claims with a clinical algorithm or a machine-learning approach. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • FDA Clears Solid Biosciences Neurodegeneration Gene Therapy IND
    FDA Clears Solid Biosciences Neurodegeneration Gene Therapy INDJanuary 13th, 2025
  • International Update on Fabry Disease and Provides Clinical Update
    International Update on Fabry Disease and Provides Clinical UpdateMay 30th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Gabriel Brooks, Dr. Gabriel Brooks, MD, Dr. G Brooks, Dr. Gabriel C Brooks